{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:01:15Z","timestamp":1792098075738,"version":"4.4.0"},"reference-count":359,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.survophthal.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T01:47:17Z","timestamp":1322617637000},"page":"474-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease"],"prefix":"10.1016","volume":"56","author":[{"given":"Khayyam","family":"Durrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad R.","family":"Zakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohiuddin","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana S.","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2011.05.003_bib1","first-page":"1374","article-title":"Treatment of orbital myositis with adalimumab (Humira)","volume":"32","author":"Adams","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib2","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0161-6420(02)01097-7","article-title":"Successful treatment of serpiginous choroiditis with alkylating agents","volume":"109","author":"Akpek","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","article-title":"Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil","volume":"136","author":"Allison","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2474-9-52","article-title":"Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety","volume":"9","author":"Alonso-Ruiz","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.survophthal.2011.05.003_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1978.03910050115002","article-title":"Immunosuppressive therapy for severe chronic uveitis","volume":"96","author":"Andrasch","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/bi00532a019","article-title":"Interaction of tubulin with single ring analogues of colchicine","volume":"21","author":"Andreu","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.survophthal.2011.05.003_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11926-003-0020-x","article-title":"B cell depletion therapy in systemic lupus erythematosus","volume":"5","author":"Anolik","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.survophthal.2011.05.003_bib10","first-page":"13","article-title":"High-dose intravenous immunoglobulin treatment in Graves\u2019 ophthalmopathy","volume":"126","author":"Antonelli","year":"1992","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/ICO.0b013e318172fbb1","article-title":"Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis","volume":"27","author":"Anzaar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2011.05.003_bib12","first-page":"123","article-title":"Pentoxifylline for the treatment of anterior uveitis in Beh\u00e7et\u2019s disease: possible alternative for TNF blockers","volume":"30","author":"Appenzeller","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2011.05.003_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bjo.84.9.979","article-title":"Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome","volume":"84","author":"Araujo","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000331979004100401","article-title":"Effect of pentoxifylline on the flow of polymorphonuclear leukocytes through a model capillary","volume":"41","author":"Armstrong","year":"1990","journal-title":"Angiology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib15","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib16","first-page":"321","article-title":"The efficacy of cyclosporin-a in the treatment of Beh\u00e7et\u2019s disease","volume":"25","author":"Atmaca","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2011.05.003_bib17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bjo.2006.097998","article-title":"Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease","volume":"90","author":"Baker","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib18","first-page":"2869","article-title":"[Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy]","volume":"138","author":"Balazs","year":"1997","journal-title":"Orv Hetil"},{"key":"10.1016\/j.survophthal.2011.05.003_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","article-title":"Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders","volume":"110","author":"Baltatzis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.110.958520","article-title":"A prospective, randomized trial of single versus dual drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial","volume":"4","author":"Baran","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.survophthal.2011.05.003_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib22","first-page":"CD000162","article-title":"Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke","volume":"2","author":"Bath","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5414\/CPP43007","article-title":"Infliximab in chronic ocular inflammation","volume":"43","author":"Baughman","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib24","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2004.061119","article-title":"Interferon as a treatment for uveitis associated with multiple sclerosis","volume":"89","author":"Becker","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib26","first-page":"CD006893","article-title":"Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn\u2019s disease","volume":"1","author":"Behm","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et\u2019s disease","volume":"70","author":"Benezra","year":"1986","journal-title":"Br J Ophthalmol"},{"issue":"3 Suppl. 4","key":"10.1016\/j.survophthal.2011.05.003_bib28","first-page":"122","article-title":"Treatment of endogenous uveitis with cyclosporine A","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","article-title":"Increased sincidence of acute leukemia in polycythemia vera associated with chlorambucil therapy","volume":"304","author":"Berk","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00417-009-1043-4","article-title":"Intravenous daclizumab for recalcitrant ocular inflammatory disease","volume":"247","author":"Bhat","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/26.4.285","article-title":"Cyclosporin A in the treatment of severe Beh\u00e7et\u2019s uveitis","volume":"26","author":"Binder","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.survophthal.2011.05.003_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/07853899708999337","article-title":"Prevention of gonadal damage during cytotoxic therapy","volume":"29","author":"Blumenfeld","year":"1997","journal-title":"Ann Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1076\/ocii.9.1.35.3983","article-title":"Use of methotrexate in the management of sight-threatening uveitis","volume":"9","author":"Bom","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib38","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/art.11104","article-title":"Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12026-009-8149-y","article-title":"High-dose cyclophosphamide for autoimmunity and alloimmunity","volume":"47","author":"Brodsky","year":"2010","journal-title":"Immunol Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archopht.1971.01000010519006","article-title":"Granulomatous sclerouveitis. Regression of ocular lesions with cyclophosphamide\u00a0and prednisone","volume":"86","author":"Brubaker","year":"1971","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.93.05080982","article-title":"Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma","volume":"5","author":"Brunnee","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.survophthal.2011.05.003_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0021-8707(69)90148-8","article-title":"Cyclophosphamide therapy of Beh\u00e7et\u2019s disease","volume":"43","author":"Buckley","year":"1969","journal-title":"J Allergy"},{"key":"10.1016\/j.survophthal.2011.05.003_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archinte.1969.00300170031006","article-title":"Cyclophosphamide therapy of peripheral uveitis","volume":"124","author":"Buckley","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/jop.2006.130","article-title":"Formulation of sirolimus eye drops and corneal permeation studies","volume":"23","author":"Buech","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09273940701299370","article-title":"A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Beh\u00e7et\u2019s disease","volume":"15","author":"Buggage","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib47","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Analgesic\u2013antipyretic and antiinflammatory agents; pharmacotherapy of gout","author":"Burke","year":"2005"},{"key":"10.1016\/j.survophthal.2011.05.003_bib48","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0701502","article-title":"Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram","volume":"122","author":"Buttini","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archinte.1986.00360160169023","article-title":"Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids","volume":"146","author":"Cade","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib50","first-page":"241","article-title":"Molecular differences in anticytokine therapies","volume":"21","author":"Calabrese","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1445-5994.2002.00262.x","article-title":"Adolescent Kawasaki disease with uveitis","volume":"32","author":"Callaway","year":"2002","journal-title":"Intern Med J"},{"key":"10.1016\/j.survophthal.2011.05.003_bib52","first-page":"23","article-title":"[Efficacy of intravenous immunoglobulin in the treatment of birdshot retinochoroiditis]","volume":"25","author":"Cassoux","year":"2002","journal-title":"J Fr Ophtalmol"},{"issue":"1A","key":"10.1016\/j.survophthal.2011.05.003_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(85)90243-8","article-title":"Review of United States data on neoplasms in rheumatoid arthritis","volume":"78","author":"Castor","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib54","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ajhp\/60.15.1531","article-title":"Monoclonal antibodies in the treatment of cancer, Part 1","volume":"60","author":"Cersosimo","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib55","series-title":"Goodman & Gilman\u2019s The Pharmacologic Basis of Therapeutics","article-title":"Antineoplastic agents","author":"Chabner","year":"2005"},{"key":"10.1016\/j.survophthal.2011.05.003_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/j.1875-9114.1987.tb04046.x","article-title":"The therapeutic use of azathioprine in renal transplantation","volume":"7","author":"Chan","year":"1987","journal-title":"Pharmacotherapy"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib57","first-page":"1","article-title":"Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events","volume":"8","author":"Chanan-Khan","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib58","first-page":"322","article-title":"Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves\u2019 ophthalmopathy and pretibial myxoedema","volume":"129","author":"Chang","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bjo.75.4.201","article-title":"Diagnosis and management of systemic Wegener\u2019s granulomatosis presenting with anterior ocular inflammatory disease","volume":"75","author":"Charles","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00161239","article-title":"Cyclosporine effects on optic nerve and retinal vasculitis in Beh\u00e7et\u2019s disease","volume":"80","author":"Chavis","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib61","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1167\/iovs.03-1373","article-title":"Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats","volume":"45","author":"Chi","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/jop.2000.16.455","article-title":"The short-term effect of pentoxifylline on rabbit choroidal blood flow","volume":"16","author":"Chou","year":"2000","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib63","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/1529-0131(200105)44:5<1048::AID-ANR184>3.0.CO;2-V","article-title":"Leflunomide-associated weight loss in rheumatoid arthritis","volume":"44","author":"Coblyn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib64","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B","article-title":"Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group","volume":"44","author":"Cohen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF00193123","article-title":"Leflunomide therapy following penetrating keratoplasty in the rat","volume":"232","author":"Coupland","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib67","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","article-title":"Natural autoantibodies","volume":"7","author":"Coutinho","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib68","first-page":"70","article-title":"Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege","volume":"39","author":"Dana","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Beh\u00e7et\u2019s disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/02713689208999530","article-title":"Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes","volume":"11","author":"de Boer","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.74.6.344","article-title":"Cyclosporin in the treatment of severe chronic idiopathic uveitis","volume":"74","author":"de Vries","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib73","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archopht.116.11.1456","article-title":"Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis","volume":"116","author":"Dees","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archinte.1967.00300020114017","article-title":"A review of therapeutic and hemolytic effects of dapsone","volume":"120","author":"DeGowin","year":"1967","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S1807-59322008000300006","article-title":"Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition","volume":"63","author":"Deree","year":"2008","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib76","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.berh.2006.06.002","article-title":"Problems encountered during anti-tumour necrosis factor therapy","volume":"20","author":"Desai","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib77","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bjo.2008.153874","article-title":"Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis","volume":"93","author":"Deuter","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib78","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/art.27581","article-title":"Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Beh\u00e7et\u2019s disease","volume":"62","author":"Deuter","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","article-title":"Methotrexate treatment for sarcoid-associated panuveitis","volume":"106","author":"Dev","year":"1999","journal-title":"Ophthalmology"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713689008999414","article-title":"Cyclosporin A treatment of Beh\u00e7et\u2019s disease: a long-term study","volume":"9","author":"Diaz-Llopis","year":"1990","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib81","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jop.2007.0104","article-title":"Adalimumab therapy for refractory uveitis: a pilot study","volume":"24","author":"Diaz-Llopis","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib82","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjo.81.12.1107","article-title":"Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A","volume":"81","author":"Dick","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3816\/CLM.2009.n.015","article-title":"Rituximab-based treatments in Waldenstrom\u2019s macroglobulinemia","volume":"9","author":"Dimopoulos","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.survophthal.2011.05.003_bib84","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.59.8.397","article-title":"Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil","volume":"59","author":"Dinning","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib85","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bjo.2006.094698","article-title":"Mycophenolate mofetil in the treatment of uveitis in children","volume":"91","author":"Doycheva","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib86","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ophtha.2003.08.034","article-title":"Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety","volume":"111","author":"Durrani","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib87","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bjo.79.3.264","article-title":"Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid","volume":"79","author":"Elder","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib88","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-2952(97)00188-3","article-title":"The effect of pentoxifylline on human neutrophil migration: a possible role for cyclic nucleotides","volume":"54","author":"Elferink","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib89","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.25904","article-title":"Dapsone-induced methemoglobinemia: A dose-related occurrence?","volume":"117","author":"Esbenshade","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2011.05.003_bib90","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1067\/mai.2001.119555","article-title":"Cyclic nucleotide phosphodiesterases","volume":"108","author":"Essayan","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7et disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib92","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0002-9343(78)90533-8","article-title":"Cyclophosphamide-induced remissions in advanced polyarteritis nodosa","volume":"64","author":"Fauci","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib94","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(94)92549-6","article-title":"Interferon-alpha 2b for refractory ocular Beh\u00e7et\u2019s disease","volume":"343","author":"Feron","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-200225030-00004","article-title":"Safety and efficacy of disease-modifying anti\u2013rheumatic agents: focus on the benefits and risks of etanercept","volume":"25","author":"Fleischmann","year":"2002","journal-title":"Drug Saf"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2011.05.003_bib96","first-page":"ii29","article-title":"Addressing the safety of anakinra in patients with rheumatoid arthritis","volume":"42","author":"Fleischmann","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib97","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/ard.2005.048371","article-title":"Safety of extended treatment with anakinra in patients with rheumatoid arthritis","volume":"65","author":"Fleischmann","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib98","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0140-6736(46)90242-5","article-title":"Mycophenolic acid; an antibiotic from Penicillium brevicompactum Dlerckx","volume":"1","author":"Florey","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib99","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis\u2013associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780110205","article-title":"Long-term cyclophosphamide therapy in rheumatoid arthritis","volume":"11","author":"Fosdick","year":"1968","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib101","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib102","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib103","series-title":"The Sclera","author":"Foster","year":"1993"},{"key":"10.1016\/j.survophthal.2011.05.003_bib104","series-title":"Beh\u00e7et\u2019s Disease: Basic and Clinical Aspects","first-page":"581","article-title":"Therapeutic response to systemic immunosuppressive chemotherapy agents in patients with Beh\u00e7et\u2019s syndrome effecting the eyes","author":"Foster","year":"1991"},{"key":"10.1016\/j.survophthal.2011.05.003_bib105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archopht.121.4.437","article-title":"Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate","volume":"121","author":"Foster","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib106","series-title":"Diagnosis and Treatment of Uveitis","article-title":"Immunosuppressive chemotherapy","author":"Foster","year":"2002"},{"key":"10.1016\/j.survophthal.2011.05.003_bib107","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clim.1999.4777","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib109","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02713689208999531","article-title":"Cytokines in human intraocular inflammation","volume":"11","author":"Franks","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(98)00372-6","article-title":"Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial","volume":"106","author":"Galindo-Rodriguez","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib111","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","article-title":"Biological response modifier therapy for refractory childhood uveitis","volume":"91","author":"Gallagher","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib112","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib113","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib114","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib115","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9394(00)00482-7","article-title":"Immunomodulatory therapy for chronic tubulointerstitial nephritis\u2013associated uveitis","volume":"129","author":"Gion","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib116","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(74)90229-3","article-title":"The use of chlorambucil in intractable idiopathic uveitis","volume":"78","author":"Godfrey","year":"1974","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib117","first-page":"1002","article-title":"Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2","volume":"88","author":"Golay","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.survophthal.2011.05.003_bib118","first-page":"111","article-title":"Blocking interleukin-1 in rheumatic diseases","volume":"1182","author":"Goldbach-Mansky","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib119","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0161-6420(01)00942-3","article-title":"Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation","volume":"109","author":"Goldstein","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib121","first-page":"401","article-title":"[Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome]","volume":"19","author":"Gonzalez-Delgado","year":"2004","journal-title":"Neurologia"},{"key":"10.1016\/j.survophthal.2011.05.003_bib122","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.1950.02910340017005","article-title":"Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions","volume":"142","author":"Gordon","year":"1950","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib123","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/08880010390232781","article-title":"Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab","volume":"20","author":"Gottardo","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"issue":"Pt 5","key":"10.1016\/j.survophthal.2011.05.003_bib124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/eye.1998.203","article-title":"The role of azathioprine in the management of retinal vasculitis","volume":"12","author":"Greenwood","year":"1998","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00347-002-0651-8","article-title":"[Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]","volume":"99","author":"Greiner","year":"2002","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2011.05.003_bib126","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ajo.2008.08.038","article-title":"Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Beh\u00e7et disease","volume":"146","author":"Gueudry","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib127","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bjo.75.6.340","article-title":"Use of cyclosporin in the management of steroid dependent non-necrotising scleritis","volume":"75","author":"Hakin","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib128","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1183\/09031936.97.10051008","article-title":"The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects","volume":"10","author":"Harbinson","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.survophthal.2011.05.003_bib129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/rheumatology\/37.10.1110","article-title":"Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial","volume":"37","author":"Hauselmann","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib130","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Antiviral agents (nonretroviral)","author":"Hayden","year":"2005"},{"key":"10.1016\/j.survophthal.2011.05.003_bib131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004397-199203210-00018","article-title":"Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis","volume":"32","author":"Hemady","year":"1992","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2011.05.003_bib132","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0161-6420(90)32485-5","article-title":"Scleritis in relapsing polychondritis. Response to therapy","volume":"97","author":"Hoang-Xaun","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib133","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2007.01.026","article-title":"Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis","volume":"114","author":"Hogan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib134","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-9394(89)90216-X","article-title":"Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis","volume":"107","author":"Holland","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib135","first-page":"142","article-title":"Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids","volume":"1","author":"Holz","year":"1992","journal-title":"Ger J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib136","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0161-6420(91)32198-5","article-title":"Triple agent immunosuppression in serpiginous choroiditis","volume":"98","author":"Hooper","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib137","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09273941003739928","article-title":"Rituximab treatment for persistent scleritis associated with rheumatoid arthritis","volume":"18","author":"Iaccheri","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib138","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib139","first-page":"711","article-title":"Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats","volume":"117","author":"Jie","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(96)00051-3","article-title":"Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats","volume":"68","author":"Jung","year":"1996","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib141","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib142","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","article-title":"Favorable response to high-dose infliximab for refractory childhood uveitis","volume":"113","author":"Kahn","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib143","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.155.10.4909","article-title":"Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages","volume":"155","author":"Kambayashi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib144","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1076\/ocii.11.2.131.15919","article-title":"Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of\u00a0uveitis and scleritis","volume":"11","author":"Kaplan-Messas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2009.01.002","article-title":"Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor","volume":"131","author":"Kaymakcalan","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib146","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib147","first-page":"148","article-title":"Long-term effects of cyclophosphamide and colchicine treatment in Beh\u00e7et\u2019s disease","volume":"23","author":"Kazokoglu","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib148","first-page":"3041","article-title":"Prevention of allergic eye disease by treatment with IL-1 receptor antagonist","volume":"40","author":"Keane-Myers","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib149","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2011.05.003_bib150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib151","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1442-9071.2009.02093.x","article-title":"Graves\u2019 ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist","volume":"37","author":"Khalilzadeh","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib152","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjo.82.7.737","article-title":"Cyclosporin A therapy in refractory non-infectious childhood uveitis","volume":"82","author":"Kilmartin","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib153","first-page":"CD004056","article-title":"Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita","volume":"1","author":"Kirtschig","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib154","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-2999(95)00232-A","article-title":"Effect of rolipram in a murine model of acute inflammation: comparison with the corticoid dexamethasone","volume":"281","author":"Klemm","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha in Beh\u00e7et disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib156","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib157","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","article-title":"Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology","volume":"37","author":"Kremer","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib158","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"1405","article-title":"Immunosuppressants, tolerogens and immunostimulants","author":"Krensky","year":"2005"},{"key":"10.1016\/j.survophthal.2011.05.003_bib159","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00162007","article-title":"Cyclosporin A treatment in two cases of corneal peripheral melting syndrome","volume":"59","author":"Kruit","year":"1985","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2011.05.003_bib161","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1074\/jbc.M611782200","article-title":"Hypoxia-inducible factor 1-alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif","volume":"282","author":"Land","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2011.05.003_bib162","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1442-9071.2003.00704.x","article-title":"Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation","volume":"31","author":"Lau","year":"2003","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib163","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(69)92051-0","article-title":"Treatment of uveitis with methotrexate","volume":"67","author":"Lazar","year":"1969","journal-title":"Am J Ophthalmol"},{"issue":"3 Suppl. 4","key":"10.1016\/j.survophthal.2011.05.003_bib164","first-page":"128","article-title":"Cyclosporine in the treatment of birdshot retinochoroidopathy","volume":"20","author":"Le Hoang","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib165","doi-asserted-by":"crossref","unstructured":"Lee FF, Foster CS. Pharmacotherapy of uveitis. Expert Opin Pharmacother. 11:1135\u201346","DOI":"10.1517\/14656561003713534"},{"key":"10.1016\/j.survophthal.2011.05.003_bib166","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/0927-3948(200003)811-SFT049","article-title":"Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy","volume":"8","author":"LeHoang","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib167","first-page":"1135","article-title":"Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer","volume":"62","author":"Lerner","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.survophthal.2011.05.003_bib168","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","article-title":"A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies","volume":"111","author":"Letko","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib169","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/sarh.2002.32586","article-title":"Relapsing polychondritis: a clinical review","volume":"31","author":"Letko","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib170","first-page":"302","article-title":"Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease","volume":"27","author":"Leznoff","year":"1992","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib171","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1442-9071.2006.01225.x","article-title":"Biologic therapies for inflammatory eye disease","volume":"34","author":"Lim","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib172","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib173","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archopht.123.7.957","article-title":"Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration","volume":"123","author":"Lim","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib174","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ajhp\/60.4.346","article-title":"Biological response modifiers in the management of rheumatoid arthritis","volume":"60","author":"Louie","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl B","key":"10.1016\/j.survophthal.2011.05.003_bib176","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib177","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/OPTH.S3308","article-title":"Interferons and their potential in the treatment of ocular inflammation","volume":"3","author":"Mackensen","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2011.05.003_bib178","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/11586290-000000000-00000","article-title":"Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies","volume":"24","author":"Magro","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.survophthal.2011.05.003_bib179","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1976.03910030274004","article-title":"Treatment of Beh\u00e7et disease with chlorambucil. A follow-up report","volume":"94","author":"Mamo","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib180","series-title":"Ocular Immunology Today","first-page":"443","article-title":"Immunosuppressive therapy of uveitis: mid- and long-term follow up after classical cytostatic treatment","author":"Martenet","year":"1990"},{"key":"10.1016\/j.survophthal.2011.05.003_bib181","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","article-title":"Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide","volume":"56","author":"Martin-Suarez","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib182","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.154.2.922","article-title":"Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis","volume":"154","author":"Martin","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib183","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et\u2019s disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib184","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.53.5.327","article-title":"Azathioprine in active chronic iridocyclitis. A double-blind controlled trial","volume":"53","author":"Mathews","year":"1969","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib185","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","article-title":"Leucocyte movement and colchicine treatment in Beh\u00e7et\u2019s disease","volume":"2","author":"Matsumura","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib186","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2169\/internalmedicine.46.6262","article-title":"Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman\u2019s disease","volume":"46","author":"Matsuyama","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib187","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","article-title":"Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group","volume":"64","author":"Mayer","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.survophthal.2011.05.003_bib188","first-page":"1358","article-title":"Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis","volume":"19","author":"McCarthy","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib189","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","article-title":"Methotrexate therapy for ocular cicatricial pemphigoid","volume":"111","author":"McCluskey","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib190","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sjogren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib191","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-198803000-00030","article-title":"Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine","volume":"45","author":"Miller","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.survophthal.2011.05.003_bib192","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0161-6420(01)00864-8","article-title":"Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"issue":"4 Suppl. 1","key":"10.1016\/j.survophthal.2011.05.003_bib193","first-page":"S169","article-title":"The molecular target of rapamycin (mTOR) as a therapeutic target against cancer","volume":"2","author":"Mita","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib194","first-page":"32","article-title":"Beh\u00e7et\u2019s disease","volume":"3","author":"Mizushima","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib195","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(77)92945-2","article-title":"Colchicine in Beh\u00e7et\u2019s disease","volume":"2","author":"Mizushima","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib196","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(14)73645-1","article-title":"A clinical trial of FK506 in refractory uveitis","volume":"115","author":"Mochizuki","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib197","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1155\/S0962935192000620","article-title":"Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors","volume":"1","author":"Molnar-Kimber","year":"1992","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib198","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","article-title":"Immunosuppressive therapy in ocular cicatricial pemphigoid","volume":"96","author":"Mondino","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib199","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.52.9.688","article-title":"Sympathetic ophthalmitis treated with azathioprine","volume":"52","author":"Moore","year":"1968","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib200","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.transproceed.2008.09.049","article-title":"Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation","volume":"40","author":"Moro","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib201","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Beh\u00e7et\u2019s disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bjo.71.5.387","article-title":"Short term cyclosporin A treatment of Beh\u00e7et\u2019s disease","volume":"71","author":"Muftuoglu","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib203","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","article-title":"Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis","volume":"123","author":"Murphy","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib204","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","article-title":"Adalimumab for sight-threatening uveitis in Beh\u00e7et\u2019s disease","volume":"21","author":"Mushtaq","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib205","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.healun.2008.07.025","article-title":"Dapsone-induced hemolytic anemia in lung allograft recipients","volume":"27","author":"Naik","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.survophthal.2011.05.003_bib206","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0161-6420(91)32209-7","article-title":"Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid","volume":"98","author":"Neumann","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib207","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1983.tb01494.x","article-title":"Studies on the pharmacokinetics of chlorambucil and prednimustine in man","volume":"15","author":"Newell","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib208","first-page":"499","article-title":"Treatment of uveitis with azathioprine (Imuran)","volume":"87","author":"Newell","year":"1967","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.survophthal.2011.05.003_bib209","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Beh\u00e7et\u2019s disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-3768.1985.tb06845.x","article-title":"The treatment of presumed non-infective uveitis with cyclosporin A","volume":"173","author":"Nissen","year":"1985","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib211","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1985.1.369","article-title":"Cyclosporine therapy for uveitis: long-term followup","volume":"1","author":"Nussenblatt","year":"1985","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib212","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib213","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","article-title":"Chlorambucil in the treatment of uveitis and meningoencephalitis of Beh\u00e7et\u2019s disease","volume":"76","author":"O\u2019Duffy","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib214","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4049\/jimmunol.164.3.1185","article-title":"Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis","volume":"164","author":"Ohta","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib215","first-page":"2591","article-title":"IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis","volume":"41","author":"Ohta","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib216","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09273940590951034","article-title":"Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature","volume":"13","author":"Okada","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib217","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00003495-200969050-00007","article-title":"Tocilizumab: a review of its use in the management of rheumatoid arthritis","volume":"69","author":"Oldfield","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2011.05.003_bib218","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/09273940601025966","article-title":"Efficacy of intravenous immunoglobulin treatment in refractory uveitis","volume":"14","author":"Onal","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib219","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Beh\u00e7et\u2019s disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Beh\u00e7et\u2019s syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib221","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09273940802204519","article-title":"Azathioprine in the management of autoimmune uveitis","volume":"16","author":"Pacheco","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"3 Suppl. 4","key":"10.1016\/j.survophthal.2011.05.003_bib222","first-page":"131","article-title":"Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine","volume":"20","author":"Palestine","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib223","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(02)01932-2","article-title":"Treatment of ocular inflammatory disorders with daclizumab","volume":"110","author":"Papaliodis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib224","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1006\/jaut.1993.1039","article-title":"Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis","volume":"6","author":"Pascalis","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.survophthal.2011.05.003_bib226","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/rheumatology\/27.1.44","article-title":"The oncogenicity of chlorambucil in rheumatoid arthritis","volume":"27","author":"Patapanian","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib227","first-page":"492","article-title":"Malignancies associated with immunosuppressive or cytotoxic therapy","volume":"83","author":"Penn","year":"1978","journal-title":"Surgery"},{"key":"10.1016\/j.survophthal.2011.05.003_bib228","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/092739490500282","article-title":"Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts Eye & Ear experience and review of previous studies","volume":"12","author":"Perez","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2011.05.003_bib229","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","article-title":"Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation","volume":"46","author":"Peters","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2011.05.003_bib230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0022-5223(96)70336-7","article-title":"A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results","volume":"111","author":"Pham","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.survophthal.2011.05.003_bib231","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib232","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/lt.500030207","article-title":"Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review","volume":"3","author":"Plotkin","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.survophthal.2011.05.003_bib233","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2007.03.050","article-title":"Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis","volume":"144","author":"Plskova","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib234","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.transproceed.2010.05.036","article-title":"Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review","volume":"42","author":"Ponticelli","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/32.4.352","article-title":"Cyclosporin A in the treatment of relapsing polychondritis with severe recurrent eye involvement","volume":"32","author":"Priori","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib236","first-page":"404","article-title":"Incidence of anemia in leprosy patients treated with dapsone","volume":"67","author":"Puavilai","year":"1984","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.survophthal.2011.05.003_bib237","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib238","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archopht.121.1.65","article-title":"Idiopathic recurrent neuroretinitis: effects of long-term immunosuppression","volume":"121","author":"Purvin","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib239","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(94)31098-0","article-title":"Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid","volume":"101","author":"Raizman","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib240","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2005.09.037","article-title":"Retrospective case review of pediatric patients with uveitis treated with infliximab","volume":"113","author":"Rajaraman","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib241","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/art.11155","article-title":"Long-term outcome of etanercept therapy in children with treatment-refractory uveitis","volume":"48","author":"Reiff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib242","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O","article-title":"Etanercept therapy in children with treatment-resistant uveitis","volume":"44","author":"Reiff","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib243","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.survophthal.2011.05.003_bib244","doi-asserted-by":"crossref","unstructured":"Restrepo JP, Molina MP. Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol. 29:559\u201361","DOI":"10.1007\/s10067-009-1368-8"},{"key":"10.1016\/j.survophthal.2011.05.003_bib245","first-page":"3044","article-title":"Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression","volume":"23","author":"Reyes","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib246","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-3-642-13443-2_16","article-title":"The cardiovascular effects of methylxanthines","volume":"200","author":"Riksen","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib247","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02713689308999487","article-title":"Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction","volume":"12","author":"Roberge","year":"1993","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib248","first-page":"CD007893","article-title":"Effect of cyclosporine on blood pressure","volume":"1","author":"Robert","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib249","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01983486","article-title":"Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats","volume":"42","author":"Robertson","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.survophthal.2011.05.003_bib250","first-page":"265","article-title":"[Case of uveitis of unknown etiology treated with nitrogen mustards. ]","volume":"41","author":"Roda Perez","year":"1951","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.survophthal.2011.05.003_bib251","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410270104","article-title":"Immunoglobulins promote remyelination in the central nervous system","volume":"27","author":"Rodriguez","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib252","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.survophthal.2011.05.003_bib253","first-page":"123","article-title":"Treatment of severe refractory uveitis with\u00a0intravenous cyclophosphamide","volume":"21","author":"Rosenbaum","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib254","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archopht.1992.01080160125049","article-title":"Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis","volume":"110","author":"Rosenbaum","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib255","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0002-9394(99)00029-X","article-title":"The treatment of refractory uveitis with intravenous immunoglobulin","volume":"127","author":"Rosenbaum","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib256","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bjo.81.2.130","article-title":"Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide","volume":"81","author":"Rosenbaum","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib257","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.4049\/jimmunol.159.12.6253","article-title":"Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram","volume":"159","author":"Ross","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib258","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib259","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/rheumatology\/keq116","article-title":"Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)","volume":"49","author":"Rubbert-Roth","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3899\/jrheum.081048","article-title":"Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis","volume":"36","author":"Rudwaleit","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib261","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a\u00a0prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib262","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0171-2985(97)80040-X","article-title":"Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation","volume":"198","author":"Ruhlmann","year":"1997","journal-title":"Immunobiology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib263","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/jop.1994.10.553","article-title":"Low dose cyclosporin-a therapy in Beh\u00e7et\u2019s disease","volume":"10","author":"Sajjadi","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib264","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib265","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib266","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.transproceed.2010.03.126","article-title":"Results with cyclosporine monotherapy in long-term cardiac transplant recipients","volume":"42","author":"Sansone","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2011.05.003_bib267","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.semarthrit.2010.07.004","article-title":"sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study","volume":"40","author":"Saougou","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib268","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib269","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib270","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.survophthal.2011.05.003_bib271","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.survophthal.2011.05.003_bib272","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.survophthal.2011.05.003_bib273","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib274","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0002-9394(14)70581-1","article-title":"A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations","volume":"121","author":"Schmetterer","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.survophthal.2011.05.003_bib276","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000310206","article-title":"Open noncontrolled multicenter long-term trial with ciclosporin in endogenous non-infectious uveitis","volume":"202","author":"Secchi","year":"1991","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2011.05.003_bib277","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0009-9120(98)00045-9","article-title":"Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression","volume":"31","author":"Sehgal","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.survophthal.2011.05.003_bib278","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjo.85.11.1287","article-title":"Intravenous immunoglobulin therapy for resistant ocular Beh\u00e7et\u2019s disease","volume":"85","author":"Seider","year":"2001","journal-title":"Br J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib279","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajo.2009.06.003","article-title":"High-dose daclizumab for the treatment of juvenile idiopathic arthritis\u2013associated active anterior uveitis","volume":"148","author":"Sen","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib280","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"issue":"Suppl 15","key":"10.1016\/j.survophthal.2011.05.003_bib281","first-page":"S109","article-title":"High-dose intravenous therapy with 7S immunoglobulins in autoimmune endocrine ophthalmopathy","volume":"14","author":"Seppel","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib282","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-0-387-89520-8_3","article-title":"Targeting TNF for treatment of cancer and autoimmunity","volume":"647","author":"Sethi","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2011.05.003_bib283","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Beh\u00e7et\u2019s disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib284","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib285","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","article-title":"Low-dose methotrexate therapy for ocular inflammatory disease","volume":"99","author":"Shah","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib286","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1359::AID-MUS26>3.0.CO;2-W","article-title":"Successful treatment of orbital myositis with intravenous immunoglobulins","volume":"21","author":"Shambal","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.survophthal.2011.05.003_bib287","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","article-title":"The efficacy of sirolimus in the treatment of patients with refractory uveitis","volume":"89","author":"Shanmuganathan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib288","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11532610-000000000-00000","article-title":"Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review","volume":"12","author":"Shenoi","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.survophthal.2011.05.003_bib289","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/art.1780390106","article-title":"Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial","volume":"39","author":"Sieper","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib290","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","article-title":"Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients","volume":"244","author":"Siepmann","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib291","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/IOP.0b013e3181c4dfde","article-title":"Rituximab for thyroid eye disease","volume":"26","author":"Silkiss","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2011.05.003_bib292","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood refractory chronic uveitis: An open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib293","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/j.2326-5205.1989.tb00014.x","article-title":"Toxic effects of azathioprine in rheumatoid arthritis. A national postmarketing perspective","volume":"32","author":"Singh","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib294","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2011.05.003_bib295","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib296","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/bjo.85.10.1220","article-title":"A role for methotrexate in the management of non-infectious orbital inflammatory disease","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib297","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","article-title":"Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis","volume":"115","author":"Sobrin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib298","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archophthalmol.2007.49","article-title":"Daclizumab for treatment of birdshot chorioretinopathy","volume":"126","author":"Sobrin","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib299","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archopht.125.7.895","article-title":"Infliximab therapy for the treatment of refractory ocular inflammatory disease","volume":"125","author":"Sobrin","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib300","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.1978.tb06537.x","article-title":"Mycophenolic acid in psoriasis","volume":"98","author":"Spatz","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib301","first-page":"737","article-title":"Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum","volume":"44","author":"Staines","year":"1981","journal-title":"Immunology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib302","doi-asserted-by":"crossref","unstructured":"Stein MR. The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins. Postgrad Med. 122:176\u201384","DOI":"10.3810\/pgm.2010.09.2214"},{"key":"10.1016\/j.survophthal.2011.05.003_bib303","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2009.141","article-title":"Infliximab therapy for refractory uveitis: 2-year results of a prospective trial","volume":"127","author":"Suhler","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib304","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporin-a therapy in severe uveitis of Beh\u00e7et\u2019s disease","volume":"76","author":"Sullu","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2011.05.003_bib306","first-page":"93","article-title":"High-dose intravenous gammaglobulin therapy for uveitis","volume":"12","author":"Sunakawa","year":"1989","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib307","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib308","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0161-6420(83)80014-1","article-title":"Chlorambucil in Beh\u00e7et\u2019s disease. A reappraisal","volume":"90","author":"Tabbara","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib309","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","article-title":"Systemic chemotherapy for ocular cicatricial pemphigoid","volume":"10","author":"Tauber","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2011.05.003_bib310","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24454","article-title":"Rituximab is effective in the treatment of refractory ophthalmic Wegener\u2019s granulomatosis","volume":"60","author":"Taylor","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib311","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1476-5381.1994.tb13073.x","article-title":"Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea pig","volume":"112","author":"Teixeira","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib312","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bjo.2006.0101477","article-title":"Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome","volume":"91","author":"Teoh","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib313","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib314","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1076\/ocii.10.2.83.13977","article-title":"The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis","volume":"10","author":"Thompson","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2011.05.003_bib315","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/eye.1989.39","article-title":"Low dose cyclosporin A therapy in chronic posterior uveitis","volume":"3","author":"Towler","year":"1989","journal-title":"Eye (Lond)"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2011.05.003_bib316","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/eye.1990.68","article-title":"Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation","volume":"4","author":"Towler","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib317","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.8378772","article-title":"Effects of oral administration of type II collagen on rheumatoid arthritis","volume":"261","author":"Trentham","year":"1993","journal-title":"Science"},{"issue":"6 Suppl. 12","key":"10.1016\/j.survophthal.2011.05.003_bib318","first-page":"79","article-title":"The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders","volume":"27","author":"Treon","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib319","first-page":"1542","article-title":"Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist","volume":"15","author":"Tsai","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2011.05.003_bib320","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","article-title":"Results of interferon-alfa therapy in patients with Beh\u00e7et uveitis","volume":"244","author":"Tugal-Tutkun","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib321","series-title":"Kelley\u2019s Textbook of Rheumatology, Vol. 1","article-title":"Anticytokine therapies","author":"Tutuncu","year":"2009"},{"key":"10.1016\/j.survophthal.2011.05.003_bib322","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","author":"Tyden","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.survophthal.2011.05.003_bib323","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","article-title":"Adalimumab in juvenile idiopathic arthritis\u2013associated chronic anterior uveitis","volume":"47","author":"Tynjala","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2011.05.003_bib324","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2133.1997.tb03770.x","article-title":"Cicatricial pemphigoid treated with intravenous immunoglobulin","volume":"137","author":"Urcelay","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib325","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ana.410320624","article-title":"Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis","volume":"32","author":"van Engelen","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib326","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000429625","article-title":"Epidemiology of intermediate uveitis. A prospective study in Savoy","volume":"23","author":"Vedot","year":"1992","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib327","doi-asserted-by":"crossref","unstructured":"Venkiteshwaran A. Tocilizumab. MAbs. 2009;1:432\u20138","DOI":"10.4161\/mabs.1.5.9497"},{"key":"10.1016\/j.survophthal.2011.05.003_bib328","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","article-title":"Dapsone as first line therapy for bullous pemphigoid","volume":"120","author":"Venning","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib329","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","article-title":"Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study","volume":"84","author":"Virtanen","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2011.05.003_bib330","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0161-6420(13)31254-8","article-title":"Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy","volume":"101","author":"Vitale","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib331","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.73.9.743","article-title":"Cyclosporin therapy for severe scleritis","volume":"73","author":"Wakefield","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib332","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/jop.1991.7.221","article-title":"Cyclosporine: a therapy in\u00a0inflammatory eye disease","volume":"7","author":"Wakefield","year":"1991","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib333","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.1780360307","article-title":"Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis","volume":"36","author":"Walker","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2011.05.003_bib334","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0161-6420(98)91120-4","article-title":"Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents","volume":"105","author":"Walton","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2011.05.003_bib335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2011.05.003_bib336","first-page":"CD003897","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"1","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2011.05.003_bib337","first-page":"35","article-title":"Toxicity of low dose methotrexate in rheumatoid arthritis","volume":"12","author":"Weinblatt","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib338","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","article-title":"Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis","volume":"133","author":"Weiss","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.survophthal.2011.05.003_bib339","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Beh\u00e7et\u2019s disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","article-title":"The mechanism of action of FK506 and cyclosporin A","volume":"696","author":"Wiederrecht","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib341","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00296-009-1111-4","article-title":"A systematic review and meta-analysis of the efficacy and safety of adalimumab for treating rheumatoid arthritis","volume":"30","author":"Wiens","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2011.05.003_bib342","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"1203","article-title":"Chemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy","author":"William","year":"2005"},{"key":"10.1016\/j.survophthal.2011.05.003_bib343","first-page":"14","article-title":"Methotrexate in the therapy of cyclitis","volume":"69","author":"Wong","year":"1965","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib344","first-page":"239","article-title":"Methotrexate treatment of uveal disease","volume":"251","author":"Wong","year":"1966","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib345","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.4049\/jimmunol.151.11.6602","article-title":"Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen\u2013induced arthritis in mice","volume":"151","author":"Wooley","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib346","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-4362.1988.tb02401.x","article-title":"Current aspects of modes of action of dapsone","volume":"27","author":"Wozel","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib347","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(10)70033-8","article-title":"Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta","volume":"9","author":"Wynn","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.survophthal.2011.05.003_bib348","first-page":"942","article-title":"Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity","volume":"40","author":"Xu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib349","first-page":"4203","article-title":"Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation","volume":"41","author":"Yamada","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2011.05.003_bib350","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/cr.2010.130","article-title":"Structural basis of immunosuppression by the therapeutic antibody daclizumab","volume":"20","author":"Yang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.survophthal.2011.05.003_bib351","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successful treatment of Beh\u00e7et disease with pentoxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib352","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et\u2019s syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2011.05.003_bib353","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaut.2008.05.001","article-title":"High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis","volume":"31","author":"Yeh","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.survophthal.2011.05.003_bib354","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2011.05.003_bib355","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","article-title":"Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review","volume":"33","author":"Youngster","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.survophthal.2011.05.003_bib356","first-page":"1427","article-title":"Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization","volume":"40","author":"Zhu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2011.05.003_bib357","doi-asserted-by":"crossref","first-page":"s50","DOI":"10.1177\/096120330501400111","article-title":"MMF and eye disease","volume":"14","author":"Zierhut","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.survophthal.2011.05.003_bib358","doi-asserted-by":"crossref","unstructured":"Zivanovic D, Medenica L, Tanasilovic S, et\u00a0al. Dexamethasone\u2013cyclophosphamide pulse therapy in pemphigus: a review of 72 cases. Am J Clin Dermatol. 11:123\u20139","DOI":"10.2165\/11311150-000000000-00000"},{"key":"10.1016\/j.survophthal.2011.05.003_bib359","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades-Beh\u00e7et disease with systemic interferon alfa","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625711000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625711000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:36:49Z","timestamp":1758541009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625711000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":359,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0039625711000890"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2011.05.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2011.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}